BR112019002023A2 - prevenção ou tratamento de infecções antifúngicas vetorizado por bactérias probióticas - Google Patents
prevenção ou tratamento de infecções antifúngicas vetorizado por bactérias probióticasInfo
- Publication number
- BR112019002023A2 BR112019002023A2 BR112019002023A BR112019002023A BR112019002023A2 BR 112019002023 A2 BR112019002023 A2 BR 112019002023A2 BR 112019002023 A BR112019002023 A BR 112019002023A BR 112019002023 A BR112019002023 A BR 112019002023A BR 112019002023 A2 BR112019002023 A2 BR 112019002023A2
- Authority
- BR
- Brazil
- Prior art keywords
- vectorized
- prevention
- treatment
- probiotic bacteria
- antifungal infections
- Prior art date
Links
- 208000015181 infectious disease Diseases 0.000 title abstract 2
- 241000894006 Bacteria Species 0.000 title 1
- 230000000843 anti-fungal effect Effects 0.000 title 1
- 229940121375 antifungal agent Drugs 0.000 title 1
- 230000002265 prevention Effects 0.000 title 1
- 239000006041 probiotic Substances 0.000 title 1
- 230000000529 probiotic effect Effects 0.000 title 1
- 235000018291 probiotics Nutrition 0.000 title 1
- 239000000203 mixture Substances 0.000 abstract 2
- 241000186605 Lactobacillus paracasei Species 0.000 abstract 1
- 230000001580 bacterial effect Effects 0.000 abstract 1
- 230000002538 fungal effect Effects 0.000 abstract 1
- 244000005700 microbiome Species 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
- A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
- A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
- A23L29/065—Microorganisms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/20—Bacteria; Culture media therefor
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/20—Bacteria; Culture media therefor
- C12N1/205—Bacterial isolates
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2200/00—Function of food ingredients
- A23V2200/30—Foods, ingredients or supplements having a functional effect on health
- A23V2200/32—Foods, ingredients or supplements having a functional effect on health having an effect on the health of the digestive tract
- A23V2200/3204—Probiotics, living bacteria to be ingested for action in the digestive tract
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2400/00—Lactic or propionic acid bacteria
- A23V2400/11—Lactobacillus
- A23V2400/165—Paracasei
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
- C12R2001/00—Microorganisms ; Processes using microorganisms
- C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
- C12R2001/225—Lactobacillus
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Biotechnology (AREA)
- Zoology (AREA)
- Genetics & Genomics (AREA)
- Wood Science & Technology (AREA)
- Microbiology (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Mycology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Virology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Nutrition Science (AREA)
- Polymers & Plastics (AREA)
- Food Science & Technology (AREA)
- Hematology (AREA)
- Communicable Diseases (AREA)
- Obesity (AREA)
- Diabetes (AREA)
- Oncology (AREA)
- Molecular Biology (AREA)
- Epidemiology (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
a invenção refere-se a um método e composições bacterianas para reduzir ou prevenir uma infecção em um tecido do corpo por um micro-organismo fúngico por contato do tecido com uma composição compreendendo uma bactéria lactobacillus paracasei purificada.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201662369735P | 2016-08-01 | 2016-08-01 | |
PCT/US2017/044703 WO2018026719A1 (en) | 2016-08-01 | 2017-07-31 | Probiotic bacteria-directed prevention or treatment of fungal infection |
Publications (1)
Publication Number | Publication Date |
---|---|
BR112019002023A2 true BR112019002023A2 (pt) | 2019-05-14 |
Family
ID=61073083
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BR112019002023A BR112019002023A2 (pt) | 2016-08-01 | 2017-07-31 | prevenção ou tratamento de infecções antifúngicas vetorizado por bactérias probióticas |
Country Status (3)
Country | Link |
---|---|
US (1) | US11478516B2 (pt) |
BR (1) | BR112019002023A2 (pt) |
WO (1) | WO2018026719A1 (pt) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US11478516B2 (en) | 2016-08-01 | 2022-10-25 | Rhode Island Hospital | Probiotic bacteria-directed prevention or treatment of fungal infection |
TWI718402B (zh) * | 2018-08-16 | 2021-02-11 | 葡萄王生技股份有限公司 | 副乾酪乳酸桿菌gks6之活性物質、含其之組合物及其促進長壽之用途 |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US9084434B2 (en) * | 2006-09-27 | 2015-07-21 | Little Calumet Holdings Llc | Probiotic oral dosage forms |
WO2011007584A1 (ja) * | 2009-07-16 | 2011-01-20 | 国立大学法人広島大学 | 口腔内疾患の予防、改善又は治療剤 |
FR2984352B1 (fr) * | 2011-12-16 | 2018-02-16 | Lesaffre Et Compagnie | Composition comprenant une biomasse microbienne active |
WO2016118738A1 (en) * | 2015-01-23 | 2016-07-28 | Intralytix, Inc. | Novel shigella bacteriophages and uses thereof |
US11478516B2 (en) | 2016-08-01 | 2022-10-25 | Rhode Island Hospital | Probiotic bacteria-directed prevention or treatment of fungal infection |
-
2017
- 2017-07-31 US US16/321,008 patent/US11478516B2/en active Active
- 2017-07-31 WO PCT/US2017/044703 patent/WO2018026719A1/en active Application Filing
- 2017-07-31 BR BR112019002023A patent/BR112019002023A2/pt active Search and Examination
Also Published As
Publication number | Publication date |
---|---|
WO2018026719A1 (en) | 2018-02-08 |
US20190151382A1 (en) | 2019-05-23 |
US11478516B2 (en) | 2022-10-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2018013583A3 (en) | Medicinal vaginal lactobacillus cocktail | |
EA202091389A1 (ru) | Композиция на основе пробиотиков и её применение | |
WO2018229236A3 (en) | COMPOSITIONS COMPRISING BACTERIAL STRAINS | |
PH12019550092A1 (en) | Virulence attenuated bacteria based protein delivery | |
PH12019502725A1 (en) | Use of lactic acid bacteria to treat or prevent at least one of postnatal depression and postnatal anxiety | |
MX2017014020A (es) | Terapia antimicrobiana. | |
PH12015502416A1 (en) | Bacterial strains having antimicrobial activity and biocontrol compositions comprising the same | |
MX2018003101A (es) | Activo de polipeptidos de lisina contra bacterias gram-negativas. | |
BR112012033212A2 (pt) | uso de lactobacillo inibindo a produção de gás de bactéria coliforme isolada em infantes afetados por cólica | |
MX2018001075A (es) | Agentes terapeuticos y profilacticos antibacterianos. | |
BR112014027842A2 (pt) | bacteriófago lisina e combinações de antibióticos contra bactérias gram-positivas | |
BR112015027536A8 (pt) | composição compreendendo bactérias ácidas lácticas para utilização no tratamento preventivo e/ou curativo de cistite recorrente. | |
MX2021002719A (es) | Cannabinoides para el tratamiento de infecciones grampositivas incluidas cepas bacterianas resistentes a antibióticos. | |
PH12019500360A1 (en) | Antibiotic compounds | |
EP3787668C0 (en) | PROBIOTIC BACTERIAL STRAINS THAT PRODUCE ANTIMICROBIAL PROTEINS AND COMPOSITIONS THEREOF FOR THE TREATMENT OF A CLOSTRIDIUM DIFFICILE INFECTION | |
PH12019502341A1 (en) | Compositions and methods involving probiotic molecules | |
BR112018014654A2 (pt) | cepa inovadora de bactérias probióticas e composições e usos da mesma | |
ZA202002093B (en) | Antibacterial compounds | |
BR112019002023A2 (pt) | prevenção ou tratamento de infecções antifúngicas vetorizado por bactérias probióticas | |
CL2017001818A1 (es) | Bacteria de ácido láctico y su uso para el tratamiento de mastitis | |
MX2022003871A (es) | Composiciones inmunogénicas. | |
EP3195870A4 (en) | Agent for promoting growth of nonpathogenic oral indigenous bacteria or agent for improving oral bacterial flora, and composition for oral use | |
MX2019006086A (es) | Uso de una composicion bacteriana para tratar infecciones en las patas de ungulados. | |
MX2020012543A (es) | Diltiazem para usarse en el tratamiento de infecciones microbianas. | |
RS57471B1 (sr) | Nova probiotička starter kultura za humanu i animalnu primenu |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B350 | Update of information on the portal [chapter 15.35 patent gazette] | ||
B06G | Technical and formal requirements: other requirements [chapter 6.7 patent gazette] | ||
B06W | Patent application suspended after preliminary examination (for patents with searches from other patent authorities) chapter 6.23 patent gazette] |